Medical Writing

We provide medical writing expertise for the full range of regulatory and clinical documents at all stages of your pre-clinical development

Schedule free 15 minute call

Medical writing is central to the successful communication of a medicinal product’s development, translating complex scientific data into clear, structured, and regulator-ready documentation.

medical writing reduces misinterpretation

Meet regulator's expectations

We present data in ways regulators expect, reducing misinterpretation and delays. By anticipating reviewer concerns, we reduce the number of major objections from regulatory authorities.

compliance

Compliance and risk reduction

Keep submissions fully aligned with evolving guidelines, minimising compliance gaps. Maintaining consistency across complex documents lowers the risk of costly errors.

Medical writing

Improve Regulatory Submissions

Translate complex science into clear, regulator-ready language, freeing internal teams to focus on strategy and innovation. Streamlining workflows and preventing costly rework from unclear documentation.

At Somerville Partners, we provide medical writing support across the full range of regulatory and clinical documents, from early development through to marketing authorisation. Our approach is grounded in regulatory science, ensuring that all documentation aligns with current expectations from European and international regulatory authorities.

Roadmap

Download our roadmap to get a step-by-step guide to working with Somerville Development Partners.

Supporting Regulatory Milestones

Throughout development, pharmaceutical and biotechnology companies are required to meet defined regulatory milestones. These milestones depend on the preparation and submission of high-quality documentation, including briefing packages, protocols, and large regulatory applications.

We support the development of these deliverables by ensuring that documents are:

  • Structured in line with regulatory guidance and submission standards
  • Scientifically accurate and internally consistent
  • Aligned with the overall regulatory and clinical strategy
    By presenting data in a way that reflects how regulators assess submissions, we help reduce ambiguity and minimise the risk of avoidable questions during review.

Consistency, Compliance and Risk Management

Regulatory documentation often spans multiple contributors, disciplines, and development stages. Maintaining consistency across these materials is essential to avoid delays or misinterpretation.

Our medical writing approach focuses on:

  • Ensuring alignment with evolving regulatory guidelines
  • Maintaining consistency across modules and document types
  • Identifying and addressing gaps or inconsistencies early

This reduces the risk of reworking submission documents and supports an efficient review process, particularly for complex submissions such as Marketing Authorisation Applications (MAAs).

Scope of Medical Writing Support We Offer

We provide medical writing services across a broad range of regulatory and clinical documents, including:

  • Orphan drug designation applications,
  • Briefing books and regulatory submission packages,
  • Clinical trial protocols and protocol synopses,
  • Investigator brochures,
  • Clinical study reports (CSRs),
  • patient narratives,
  • Paediatric Investigation Plans (PIPs) and paediatric study plans, and
  • Full Common Technical Document (CTD) modules (Modules 1–5) for registrational submissions.

Our work spans both standalone document preparation and integrated dossier development, depending on the needs of your programme.

Clinical Trial Protocol Development

The clinical trial protocol is a critical component of your regulatory strategy and a key focus during regulatory interactions.

We support protocol development by:

  • Advising on study design requirements for registration
  • Structuring protocols in line with regulatory expectations
  • Preparing protocol synopses and full clinical protocols
  • Incorporating input from key opinion leaders and advisory boards where appropriate

Well-structured protocols support more effective engagement with regulators and form a strong foundation for later-stage submissions.

Integrated with your Regulatory Strategy

Medical writing is not delivered in isolation. As a regulatory affairs consultancy, our work is integrated with broader regulatory planning, scientific advice, and development strategy.

This ensures that documentation:

  • Reflects the intended regulatory pathway
  • Reflects the intended regulatory pathway
  • Aligns with long-term submission strategy and lifecycle planning

This integrated approach reflects how regulatory authorities assess submissions in practice, where clarity, consistency, and strategic alignment are critical.

A Scientific and Regulatory Perspective

Our team consists of experienced regulatory professionals with backgrounds in both industry and consultancy. This enables us to approach medical writing from a regulatory reviewer’s perspective, anticipating potential questions and areas of focus.

We work collaboratively with your internal teams to ensure that documents are technically robust, strategically aligned, and ready for submission.

years of regulatory expertise

clients supported

agency interactions

orphan applications

marketing applications

Subscribe to our Monthly Regulatory Intelligence Scan

Our monthly newsletter gives you the latest European and UK regulatory intelligence. We bring you new and interesting approvals; fast-to-market applications, orphan designations; paediatric applications and therapy area-specific news.

Newsletter Optin

You can unsubscribe at any time from the link in the newsletter footer. Read our Privacy Policy here.